Literature DB >> 28976443

Research on Somatization and Somatic Symptom Disorders: Ars longa, vita brevis.

Joel E Dimsdale1.   

Abstract

The new Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition defines somatic symptom and related disorders as long-standing somatic symptoms that are associated with disproportionate thoughts, feelings, and behaviors, irrespective of whether or not a medical cause for these symptoms can be determined. In this Special Section of Psychosomatic Medicine, several articles address diagnostic issues and the central nervous system correlates of somatic symptom and related disorder and document new developments in its treatment.

Entities:  

Mesh：

Year:  2017        PMID： 28976443      PMCID： PMC5675784          DOI： 10.1097/PSY.0000000000000533

Source DB:  PubMed          Journal:  Psychosom Med        ISSN： 0033-3174            Impact factor:   4.312


  14 in total

1.  Assessing the New DSM-5 Diagnosis of Somatic Symptom Disorder.

Authors:  Arthur J Barsky
Journal:  Psychosom Med       Date:  2016-01       Impact factor: 4.312

2.  Somatic symptom disorder: an important change in DSM.

Authors:  Joel E Dimsdale; Francis Creed; Javier Escobar; Michael Sharpe; Lawson Wulsin; Arthur Barsky; Sing Lee; Michael R Irwin; James Levenson
Journal:  J Psychosom Res       Date:  2013-07-25       Impact factor: 3.006

3.  Medically unexplained symptoms: a treacherous foundation for somatoform disorders?

Authors:  Joel E Dimsdale
Journal:  Psychiatr Clin North Am       Date:  2011-07-23

4.  Core Outcome Domains for Clinical Trials on Somatic Symptom Disorder, Bodily Distress Disorder, and Functional Somatic Syndromes: European Network on Somatic Symptom Disorders Recommendations.

Authors:  Winfried Rief; Chris Burton; Lisbeth Frostholm; Peter Henningsen; Maria Kleinstäuber; Willem J Kop; Bernd Löwe; Alexandra Martin; Ulrik Malt; Judith Rosmalen; Andreas Schröder; Meike Shedden-Mora; Anne Toussaint; Christina van der Feltz-Cornelis
Journal:  Psychosom Med       Date:  2017 Nov/Dec       Impact factor: 4.312

5.  Effectiveness of a Stepped, Collaborative, and Coordinated Health Care Network for Somatoform Disorders (Sofu-Net): A Controlled Cluster Cohort Study.

Authors:  Bernd Löwe; Katharina Piontek; Anne Daubmann; Martin Härter; Karl Wegscheider; Hans-Helmut König; Meike Shedden-Mora
Journal:  Psychosom Med       Date:  2017 Nov/Dec       Impact factor: 4.312

6.  Influence of Uncertain Anticipation on Brain Responses to Aversive Rectal Distension in Patients With Irritable Bowel Syndrome.

Authors:  Michiko Kano; Tomohiko Muratsubaki; Joe Morishita; Keiji Kono; Shunji Mugikura; Kei Takase; Huynh Giao Ly; Patrick Dupont; Lukas Van Oudenhove; Shin Fukudo
Journal:  Psychosom Med       Date:  2017 Nov/Dec       Impact factor: 4.312

7.  Screening for DSM-5 Somatic Symptom Disorder: Diagnostic Accuracy of Self-Report Measures Within a Population Sample.

Authors:  Johannes A C Laferton; Nikola M Stenzel; Winfried Rief; Kristina Klaus; Elmar Brähler; Ricarda Mewes
Journal:  Psychosom Med       Date:  2017 Nov/Dec       Impact factor: 4.312

8.  Features of Resting-State Electroencephalogram Theta Coherence in Somatic Symptom Disorder Compared With Major Depressive Disorder: A Pilot Study.

Authors:  Jaeyoung Ahn; Doug Hyun Han; Ji Sun Hong; Kyoung Joon Min; Young Sik Lee; Bong-Jin Hahm; Sun Mi Kim
Journal:  Psychosom Med       Date:  2017 Nov/Dec       Impact factor: 4.312

9.  An Attachment-Based Model of the Relationship Between Childhood Adversity and Somatization in Children and Adults.

Authors:  Robert G Maunder; Jonathan J Hunter; Leslie Atkinson; Meir Steiner; Ashley Wazana; Alison S Fleming; Ellen Moss; Helene Gaudreau; Michael J Meaney; Robert D Levitan
Journal:  Psychosom Med       Date:  2017-06       Impact factor: 4.312

Review 10.  Efficacy of treatment for somatoform disorders: a review of randomized controlled trials.

Authors:  Kurt Kroenke
Journal:  Psychosom Med       Date:  2007-12       Impact factor: 4.312
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.